Table 1.
Baseline characteristics of Malaysia children at initiation of ART
| Characteristics | N |
|---|---|
| All patients | 278 |
| Female, n (%) | 133 (48%) |
| Age, median (IQR) years | 4.2 (1.4–7.4) |
| Baseline WHO stage, n (%) | |
| Stage 1 | 91 (33%) |
| Stage 2 | 39 (14%) |
| Stage 3 | 90 (32%) |
| Stage 4 | 58 (21%) |
| ART regimen | |
| ART with PI | 51 (18%) |
| ART without PI | 227 (82%) |
| CD4 percentage | |
| <5% | 41 (15%) |
| 5 to <15% | 45 (16%) |
| 15 to <25% | 44 (16%) |
| ≥25% | 27 (10%) |
| Unknown | 121 (44%) |
| Median (IQR) | 13 (4–21) |
| CD4 cell count (×106 cells/L) | |
| <50 | |
| 50 to <250 | 53 (19%) |
| 250 to <500 | 54 (19%) |
| 500 to <1000 | 42 (15%) |
| ≥1000 | 42 (15%) |
| Unknown | 34 (12%) |
| Median (IQR) | 53 (19%) |
| 272 (60–725) | |
| Median HIV RNA log 10 copies/ml (n = 162) | 5.4 (4.9–5.9) |
| Baseline weight for age z score, median (n = 244) | −2.6 (−3.9 to −1.3) |
| Baseline height for age z score, Median (n = 241) | −2.1 (−2.8 to −1.1) |
| Severe anaemia n (%) (n = 192) | 66 (24%) |
| Family status up to 1 year after baseline (n = 173) | 61 (22%) |
| Both parents involved | 54 (19%) |
| Single parent involved | 58 (21%) |
| Orphan | 105 (38%) |
| Unknown | |
ART, anti-retroviral therapy; HIV, human immunodeficiency virus; IQR, interquartile range; WHO, World Health Organization.